ATE40521T1 - Verwendung eines substanzgemisches fuer die herstellung eines mittels gegen buergers krankheit. - Google Patents

Verwendung eines substanzgemisches fuer die herstellung eines mittels gegen buergers krankheit.

Info

Publication number
ATE40521T1
ATE40521T1 AT84102855T AT84102855T ATE40521T1 AT E40521 T1 ATE40521 T1 AT E40521T1 AT 84102855 T AT84102855 T AT 84102855T AT 84102855 T AT84102855 T AT 84102855T AT E40521 T1 ATE40521 T1 AT E40521T1
Authority
AT
Austria
Prior art keywords
disease
bürger
substances
manufacture
mixture
Prior art date
Application number
AT84102855T
Other languages
English (en)
Inventor
Hidenori Yorozu
Yasuteru Eguchi
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Application granted granted Critical
Publication of ATE40521T1 publication Critical patent/ATE40521T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT84102855T 1983-11-22 1984-03-15 Verwendung eines substanzgemisches fuer die herstellung eines mittels gegen buergers krankheit. ATE40521T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58220246A JPS60112717A (ja) 1983-11-22 1983-11-22 バ−ジヤ−病治療剤組成物
EP84102855A EP0142597B1 (de) 1983-11-22 1984-03-15 Verwendung eines Substanzgemisches für die Herstellung eines Mittels gegen Buergers Krankheit

Publications (1)

Publication Number Publication Date
ATE40521T1 true ATE40521T1 (de) 1989-02-15

Family

ID=16748179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84102855T ATE40521T1 (de) 1983-11-22 1984-03-15 Verwendung eines substanzgemisches fuer die herstellung eines mittels gegen buergers krankheit.

Country Status (6)

Country Link
EP (1) EP0142597B1 (de)
JP (1) JPS60112717A (de)
AT (1) ATE40521T1 (de)
CA (1) CA1215323A (de)
DE (1) DE3476520D1 (de)
NO (1) NO841275L (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62181219A (ja) * 1986-02-04 1987-08-08 Kao Corp 褥瘡治療剤
US5198144A (en) * 1988-04-01 1993-03-30 Kao Corporation Bathing preparation
WO2003055476A1 (en) * 2001-12-25 2003-07-10 Pomytkin Igor A Use of succinic acid and salts thereof for inhibiting platelet aggregation
DE10327432A1 (de) * 2003-06-18 2005-01-05 Beiersdorf Ag Bei Entnahme reaktiv aufschäumendes kohlesäurenhaltiges Hautpflegeprodukt
JP2010024184A (ja) * 2008-07-22 2010-02-04 Tsumura Lifescience Co Ltd むくみ改善組成物およびそれを利用したむくみ改善方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR722490A (fr) * 1931-09-05 1932-03-17 Novopin Fabrik Pharmacosma G M Perfectionnements à la fabrication des tablettes pour le bain

Also Published As

Publication number Publication date
EP0142597A3 (en) 1985-07-03
EP0142597B1 (de) 1989-02-01
EP0142597A2 (de) 1985-05-29
DE3476520D1 (en) 1989-03-09
JPS6411619B2 (de) 1989-02-27
NO841275L (no) 1985-05-23
CA1215323A (en) 1986-12-16
JPS60112717A (ja) 1985-06-19

Similar Documents

Publication Publication Date Title
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
SE8403487L (sv) Farmaceutisk komposition
ATE31625T1 (de) Pharmazeutisches mittel zur behandlung des diabetes mellitus.
ATE76288T1 (de) Feste pharmaceutische zubereitung mit verlaengerter wirkstofffreigabe und verfahren zur herstellung.
FI870219A (fi) Hypoglykemiska tiazolidindioner.
SE8102194L (sv) Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
DE3778770D1 (de) Neue diphenylpropylamin-derivate, ihre herstellung sowie ihre pharmazeutische verwendung.
DE3689117T2 (de) Pharmazeutische Zusammensetzung mit Gehalt an einer Mischung von Kollagen und einem antiseptischen und/oder entzündungshemmenden Wirkstoff und Verfahren zu ihrer Herstellung.
DE69615984D1 (de) Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen
PT80820B (pt) Processo para a preparacao de derivados de 1,3-propilidenodifosfonato 2-substituidos
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
IT1182854B (it) Composizione anestesica percutanea per impiego topico e procedimento d'applicazione
ATE40521T1 (de) Verwendung eines substanzgemisches fuer die herstellung eines mittels gegen buergers krankheit.
DE68917937T2 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
ATE34662T1 (de) Derivate der benzoesaeure, herstellungsverfahren und anwendung in desinfizierenden und konservierenden arzneimitteln.
ES534859A0 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquilsulfonilfenil)-2-amino-1,3-propandiol n-substituidos
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
ATE86105T1 (de) Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie.
DE3372756D1 (en) Substituted benzenesulfonic acid esters, preparation thereof and their use as medicaments
JPS5513285A (en) Imidazoline compound and medical composition
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
SE8402361D0 (sv) Novel acylaminophenol derivatives
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69517247D1 (de) Phosphorylierte Derivate von Verbindungen mit antiinflammatorischen oder analgetischer Wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee